| High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence CS Bradshaw, AN Morton, J Hocking, SM Garland, MB Morris, LM Moss, ... The Journal of infectious diseases 193 (11), 1478-1486, 2006 | 918 | 2006 |
| Sexually transmitted infections: challenges ahead M Unemo, CS Bradshaw, JS Hocking, HJC de Vries, SC Francis, ... The Lancet infectious diseases 17 (8), e235-e279, 2017 | 811 | 2017 |
| The role of lactic acid production by probiotic Lactobacillus species in vaginal health G Tachedjian, M Aldunate, CS Bradshaw, RA Cone Research in microbiology 168 (9-10), 782-792, 2017 | 528 | 2017 |
| Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis KA Fethers, CK Fairley, JS Hocking, LC Gurrin, CS Bradshaw Clinical Infectious Diseases 47 (11), 1426-1435, 2008 | 468 | 2008 |
| Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women YC Ai-ris, K McMahan, J Yu, LH Tostanoski, R Aguayo, J Ansel, ... Jama 325 (23), 2370-2380, 2021 | 463 | 2021 |
| Azithromycin Treatment Failure in Mycoplasma genitalium–Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance JS Jensen, CS Bradshaw, SN Tabrizi, CK Fairley, R Hamasuna Clinical Infectious Diseases 47 (12), 1546-1553, 2008 | 414 | 2008 |
| The Association of Atopobium vaginae and Gardnerella vaginalis with Bacterial Vaginosis and Recurrence after Oral Metronidazole Therapy CS Bradshaw, SN Tabrizi, CK Fairley, AN Morton, E Rudland, SM Garland The Journal of infectious diseases 194 (6), 828-836, 2006 | 377 | 2006 |
| Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure CS Bradshaw, SN Tabrizi, TRH Read, SM Garland, CA Hopkins, LM Moss, ... The journal of infectious diseases 193 (3), 336-345, 2006 | 370 | 2006 |
| The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme TRH Read, JS Hocking, MY Chen, B Donovan, CS Bradshaw, CK Fairley Sexually transmitted infections 87 (7), 544-547, 2011 | 343 | 2011 |
| Current treatment of bacterial vaginosis—limitations and need for innovation CS Bradshaw, JD Sobel The Journal of infectious diseases 214 (suppl_1), S14-S20, 2016 | 294 | 2016 |
| Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women CK Fairley, JS Hocking, LC Gurrin, MY Chen, B Donovan, CS Bradshaw Sexually transmitted infections 85 (7), 499-502, 2009 | 283 | 2009 |
| Azithromycin failure in Mycoplasma genitalium urethritis CS Bradshaw, JS Jensen, SN Tabrizi, TRH Read, SM Garland, ... Emerging infectious diseases 12 (7), 1149, 2006 | 266 | 2006 |
| The burden of bacterial vaginosis: women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis JE Bilardi, S Walker, M Temple-Smith, R McNair, J Mooney-Somers, ... PloS one 8 (9), e74378, 2013 | 262 | 2013 |
| The evolving facets of bacterial vaginosis: implications for HIV transmission LR McKinnon, SL Achilles, CS Bradshaw, A Burgener, T Crucitti, ... AIDS research and human retroviruses 35 (3), 219-228, 2019 | 259 | 2019 |
| Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis DA Machalek, Y Tao, H Shilling, JS Jensen, M Unemo, G Murray, ... The lancet infectious diseases 20 (11), 1302-1314, 2020 | 239 | 2020 |
| Macrolide Resistance and Azithromycin Failure in a Mycoplasma genitalium–Infected Cohort and Response of Azithromycin Failures to Alternative Antibiotic … M Bissessor, SN Tabrizi, J Twin, H Abdo, CK Fairley, MY Chen, ... Clinical infectious diseases 60 (8), 1228-1236, 2015 | 230 | 2015 |
| Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis CS Bradshaw, AN Morton, SM Garland, MB Morris, LM Moss, CK Fairley Obstetrics & Gynecology 106 (1), 105-114, 2005 | 226 | 2005 |
| Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use CS Bradshaw, LA Vodstrcil, JS Hocking, M Law, M Pirotta, SM Garland, ... Clinical Infectious Diseases 56 (6), 777-786, 2013 | 224 | 2013 |
| Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis LA Vodstrcil, JS Hocking, M Law, S Walker, SN Tabrizi, CK Fairley, ... PloS one 8 (9), e73055, 2013 | 218 | 2013 |
| Persistence of Mycoplasma genitalium following azithromycin therapy CS Bradshaw, MY Chen, CK Fairley PloS one 3 (11), e3618, 2008 | 198 | 2008 |
Christopher Fairley AOCentral Clinical School Monash Univerity, Melbourne Sexual Health Centre Alfred HealthEmail verificata su monash.edu